Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ISCOTEC
Uppsala, Sweden
- Ownership
- Private
- Development stage
- Other
01
Overview
Iscotec AB is a Swedish biotechnology company specializing in the development and commercialization of vaccine response enhancers and adjuvants. The company is best known for its pioneering work on immunostimulating complexes (ISCOMs) and ISCOMATRIX, which are cage-like nanoparticle adjuvants composed of saponins (specifically Quil A fractions), cholesterol, and phospholipids. These adjuvants are designed to enhance both humoral and cellular immune responses, including cytotoxic T lymphocyte (CTL) activation, making them highly valuable for prophylactic and therapeutic vaccines. Acquired by CSL Limited, Iscotec's technology has been widely utilized in clinical trials for various infectious diseases and cancer vaccines.
- Therapeutic areas
- Infectious DiseasesOncology
- Modalities
- Vaccine adjuvantBiologic
- Industry
- Biotech
02
Partnerships
Merck & CoLudwig Institute for Cancer Research
Beyond the preview
Go deeper on ISCOTEC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ISCOTEC.